KLRS Stock Analysis: Buy, Sell, or Hold?
KLRS - Kalaris Therapeutics, Inc. Common Stock
$4.05
-0.03 (-0.74%)
âŧ
5d:
+2.79%
30d:
-7.53%
90d:
-17.35%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When KLRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KLRS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KLRS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KLRS is currently trading at $4.05, which is considered fair relative to its 30-day fair value range of $3.68 to $4.42.
Technical Outlook: Technically, KLRS is in a strong downtrend. Immediate support is located at $3.46, while resistance sits at $4.40.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.71 (+358.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KLRS is in a strong downtrend. Immediate support is located at $3.46, while resistance sits at $4.40.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.71 (+358.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.68 -
$4.42
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 358.7% below Wall St target ($18.71)
- WARNING: Composite score 37/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.68 -
$4.42
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.46
Resistance Level
$4.40
Current Trend
Strong Downtrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.51
Wall Street Target
$18.71
(+358.7%)
Share & Embed Analysis
Last updated: August 17, 2026 12:01 PM ET
Data refreshes hourly during market hours. Next update: 1:01 PM
Data refreshes hourly during market hours. Next update: 1:01 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KLRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Brett R Hagen
SELL
1915 shares
2026-03-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$372 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 33 SELL |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$563 | 32 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 52 HOLD |
